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expression and mycobacterium tuberculosis
induced IP-10 and IL-8 synthesis via interference
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Background: Our previous study showed NF-κB repressing factor (NKRF) downregulates IP-10 and IL-8 synthesis
in the peripheral blood mononuclear cells and alveolar macrophages of TB patients with high bacterial loads.
However, the mechanism underlying the repressive effect of NKRF is not fully understood.
Results: The levels of IP-10, IL-8 and NKRF were significantly up-regulated in THP-1 cells treated with heated
mycobacterium tuberculosis (H. TB). NKRF inhibited NF-κB-mediated IP-10 and IL-8 synthesis and release induced
by H. TB. The repressive effect of NKRF is mediated via interference with NF-κB (p65) binding and RNA polymerase II
recruitment to promoter sites of IP-10 and IL-8.
Conclusions: We have elucidated that direct contact with MTb induces IP-10, IL-8 and a concomitant increase in
NKRF in THP-1 cells. The up-regulated NKRF serves as an endogenous repressor for IP-10 and IL-8 synthesis to
hinder host from robust response to MTb infection.
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Tuberculosis (TB) killed an estimated 100 million people
over the last century [1-3]. About one third of the world’s
population is infected with Mycobacterium tuberculosis
(MTb). Most of the infected persons never develop an ac-
tive disease [1-3] because the host immune response keeps
the infection under control. After MTb infection, innate
immunity initially predominates the subsequent response
in the host. For the purpose to contain MTb, T lympho-
cytes are recruited to the lung within granulomas, which
consist of activated macrophages, T lymphocytes, fibro-
blasts, and epitheloid cells [4]. To prevents the disease re-
activation, a complex interaction between different cell
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unless otherwise stated.Specific chemokines, such as IP-10, IL-8, MIG/CXCL9
and MCP-1/CCL2 are released from monocytes, alveolar
macrophages and polymorphonuclear granulocytes to re-
cruit NK cells, γδ T lymphocytes, and αβ T lymphocytes
of CD4+ and CD8+ phenotypes in sequential order into
the site of MTb infection [5-9].
IP-10, a member of the α-chemokine subfamily, is in-
volved in delayed type hypersensitivity [10]. It promotes
Th1 responses and IFN-γ gene expression [11], and
attracts monocytes and activated T lymphocytes to in-
flammatory foci [12]. High levels of IP-10 were detected
in TB patient’s sera [13,14] and bronchoalveolar lavage
[13,15]. Except for chemotaxis, IP-10 also contributes to
the necrosis of tuberculous granulomas by inhibiting
angiogenesis [16].
Enhanced IL-8 release and gene expression in macro-
phages or monocytes has been shown after exposure to
MTb and its components [17,18]. IL-8 gene polymorphism
is associated with susceptibility to TB [19], and in HIV-
infected patients [20]. IL-8 is necessary for granulomaLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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enhances the abilities in macrophage killing MTb [22].
The induction of both IP-10 and IL-8 by MTb is NF-κB
dependent [16,23]. Our previous study showed NF-κB
repressing factor (NKRF) is upregulated in the circulating
monocytes and alveolar macrophages of patients with ac-
tive pulmonary TB, and inhibits synthesis and release of
IP-10 and IL-8 [13]. NKRF is a transcriptional silencer and
is implicated in the basal silencing of specific NF-κB tar-
geting genes, including iNOS, IFN-β and IL-8 [24-26].
NKRF only interacts with specific NRE (negative regula-
tory element) to mediate NF-κB transcriptional silencing.
NKRF specific NREs are only found in certain NF-κB tran-
scriptional genes in certain cells [24-26]. However, the
mechanism underlying NKRF up-regulation and its silen-
cing effect on IP-10 and IL-8 in MTb infected monocytes
has not been clearly explored. In the present study, we
have demonstrated that direct exposure to MTb upregu-
lates NKRF expression in monocytes, and the repressive
effect of NKRF on IP-10 and IL-8 synthesis might be via
interfering with NF-κB (P65) binding and RNA poly-
merase II recruitment to their promoter sites.
Methods
Cell preparation and culture
THP-1 cells purchased from the ATCC (TIB202) were
grown in suspension in T-150 tissue culture flasks in
RPMI 1640 (GIBCO, Grand Island, NY, USA) supple-
mented with 10% fetal calf serum (FCS, Flow Laboratories,
Paisley, Scotland, UK). Cells (1 × 106 cells/ml) were pre-
treated with or without NF-κB specific inhibitor Helenalin
(Merck KGaA, Darmstadt, Germany) half hour before
incubation with or without heated TB bacilli (H37-RA)
(H. TB) (DIFCO) for various time points (6, 24, 72 hrs).
The culture supernatant was collected and frozen at −70°C
before analysis for assay of IP-10 and IL-8 by ELISA with
commercial ELISA kits (R&D Systems, Minneapolis, MN).
The levels of cytokine secretion could vary among dif-
ferent passages of the target cells, e.g., THP-1 cells. In each
experimental study, the same passage of cultured cells was
used to minimize the variation. The control group from
the same passage was used to justify a similar response as
that in different passage of cultured cells.
Quantitative real-time PCR (qPCR)
Total RNA was isolated from cells using TRIzol reagent
(Invitrogen, Grand Island, NY) according to the manufac-
turer’s instruction. cDNA was reversely-transcribed from
isolated RNA by incubating 200 ng of DNase-treated
RNA with the first-strand synthesis kit (Advanced Bio-
technologies). qPCR was performed in a LightCycler 2.0
System (Roche Applied Science) using LightCycler DNA
Master SYBR Green I (Roche Applied Science). Samples
were denatured at 95°C for 10 min, followed by 45 cyclesof annealing and extension at 95°C for 15 s, 60°C for 5 s,
and 72°C for 10 s. Melting curves were obtained at the
end of amplification by cooling the samples to 65°C for
15 s, followed by further cooling to 40°C for 30 s.
Data were analyzed by standard curve method of rela-
tive quantification using the LightCycler analysis software.
Quantification of NF-κB p65 DNA-binding activity
(TransAM assay)
To determine the alteration of NF-κB activity by MTb in
THP-1 cells, the level of NF-κB subunits p50, p52, p65,
C-Rel and RelB activity was measured using the NF-κB
TransAM kit (Active Motif) according to the manufac-
turer’s instructions. Briefly, cells nuclear extraction were
prepared by using the Nuclear Extract Kit (Active Motif)
and protein concentrations were measured using the
Bradford assay (Bio-Rad). Lysates (10 μg total proteins)
were incubated in ELISA wells coated with the NF-κB
consensus site (5′-GGGACTTTCC -3′) recognized by ac-
tive NF-κB subunits p50, p52, p65, C-Rel and RelB, then
they were detected using a specific antibody, followed by a
secondary antibody conjugated to peroxidase.
Immunostaining and confocal microscopic analysis
THP-1 cells treated with or without H. TB were spun
down on slide then fixed in methanol at −20°C for 5 min.
The cells were then blocked with 1% BSA/PBS at room
temperature for 30 min and incubated with the rabbit anti
human NKRF Ab at room temperature for 1 hr. After
washing, the cells were incubated with a Cy3-conjugated
anti-rabbit Ab (Chemicon International) and incubated
with Hoechst dye (Sigma-Aldrich). After washing and air-
drying, the cells were mounted with anti-fade mounting
medium (Dako Cytomation). Images were acquired with a
confocal laser-scanning microscope (Leica) and analyzed
by Metamorph Image Analysis (Universal Imaging).
Western blot analysis
Total cellular proteins were extracted from THP-1 cells by
freeze-thawing samples in Reporter lysis buffer (Promega).
Proteins were subjected to 7.5% SDS-PAGE and blotted
onto nitrocellulose filters. NKRF was detected with β-actin
(sigma) and an alkaline phosphatase-conjugated anti-mouse
secondary Ab (1/100,000 dilution; Calbiochem) or specific
anti-NKRF Ab and an alkaline phosphatase-conjugated
anti-rabbit secondary Ab (1/10,000 dilution; Calbiochem).
Blots were incubated with ECL solution (LumiGLO;
Amersham Bioscience). Images were acquired and ana-
lyzed using G: BOX (Syngene).
Transfection of siRNA and plasmids
To knockdown NKRF expression, Si-RNA (Si-Scramble
and Si-NKRF) were introduced into THP-1 cells. Plasmid
DNA (p-CMV and p-CMV-NKRF) were introduced into
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can regulate the release of IP-10 and IL-8. The trans-
fection of THP-1 cells (1 × 106 cells/ml) was performed by
lipofectamine 2000 kit (Invitrogen, Grand Island, NY). We
diluted 20 pmol siRNA oligomer (or 1 μg plasmid DNA)
in 50 μl Opti-MEM medium (Invitrogen, Grand Island,
NY) without serum to mix gently. Then, 1 μl Lipofecta-
mine 2000 in 50 μl Opti- MEM medium was diluted to
mix gently and incubate for 5 minutes at room tem-
perature. The diluted oligomer and diluted Lipofectamine
2000 were mixed and incubated for 20 minutes at room
temperature. We added the oligomer (DNA)- Lipofecta-
mine 2000 complexes to each well containing 0.5 ml cells
and medium. The cells were incubated at 37°C in a CO2
incubator for 6 hrs. After transfection, cells were incu-
bated in complete medium for 48 hrs (for si-RNA) or 24
hrs (for plasmid DNA). The transfection efficiency in
THP-1 cells was 53.4% for siRNA and 56.3% for plasmid
DNA. The supernatant of cell after 6 hrs culture was col-
lected for ELISA. The protein of transfected THP-1 cells
was harvested for Western blot analysis.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were preformed as described previously
[13,27]. After stimulation, protein-DNA complexes were
cross-linked at 37°C for 10 min by formaldehyde (1%
final concentration). Twenty μl (1%) of ChIP dilution
solution was kept as input control. The remained diluted
solution was precleared by incubating with 80 μl of
salmon sperm DNA/protein A-agarose-50% slurry for
30 min at 4°C on a rotator. After centrifuge, 900 μl of the
supernatant was immunoprecipitated at 4°C overnight on
a rotator by using Abs specific for NKRF (5 μg), IgG
(Santa Cruz Biotechnology) followed by incubation for
1 hr at 4°C with 60 μl of salmon sperm DNA/protein
A-agarose-50% slurry. Protein-bound immunoprecipitated
DNA (IP-DNA) was sequentially washed with low-salt or
high-salt immune complex wash buffers. Immune com-
plexes were eluted twice by adding 250 μl of elution buffer
(1% SDS/0.1 M NaHCO3). DNA-protein cross-links were
reversed by incubation for 4 hrs at 65°C in 200 mM NaCl/
1% SDS, and proteins were digested by incubation for 1 hr
at 45°C with 70 μg/ml proteinase K (Sigma-Aldrich). DNA
was isolated with phenol/chloroform, precipitated with
ethanol/0.3 M NaHCOOH/20 μg of glycogen and was re-
suspended in 50 μl of nuclease- free water. qPCR was per-
formed with 7 μl of DNA sample for quantification.
Statistical analysis
Data were expressed as mean ± SE. The data were ana-
lyzed with Student’s t test for paired or unpaired data. For
data with uneven variation, the Mann–Whitney U test or
Wilcoxon’s signed ranks test was used for unpaired or
paired data, respectively. Statistical significance of resultswas determined using prism4 software. A value of p < 0.05
was considered statistically significant.
Results
Increased mRNA expression and protein release of IP-10
and IL-8 in H. TB treated THP-1 cells
After treatment with or without H. TB, THP-1 cells were
harvested for q-PCR and the supernatant was collected
for ELISA. The expression of mRNA and NF-κB subunit
activation were observed at 2 hour, while protein expres-
sion and ChIP assay were observed at 6 hour and 1 hour,
respectively throughout the study. The viability deter-
mined by MTT assay was significantly decreased when
THP-1 cells treated with 20 μg/ml H. TB (81.7 ± 1.0% of
control) (Figure 1A). Among non-cytotoxic concentra-
tions (H. TB 2.5, 5, 10 μg/ml), 10 μg/ml induced the ma-
ximal and 5 μg/ml induced the submaximal cytokines
secretion responses. We therefore defined H. TB 10 μg/ml
as the highest non-cytotoxic concentration and 5 μg/ml as
submaximal concentration in this study. H. TB induced
increases in the levels of mRNA and protein of IP-10 and
IL-8 in a concentration-dependent manner (Figures 1B,
C). When treatment with H. TB for 2 hrs, the mRNA levels
of IP-10 significantly increased at 5 μg/ml of H. TB (n = 5),
reaching the maximum at 10 μg/ml (n = 5) (Figure 1B). The
levels of IL-8 mRNA significantly increased at 2.5 μg/ml of
H. TB (n = 5), reaching the maximum at 10 μg/ml (n = 5)
(Figure 1B), when compare to the vehicle controls (n = 5,
P < 0.05 respectively). When treatment with H. TB for 6
hrs, the protein of IP-10 significantly increased at 2.5 μg/ml
of H. TB, reaching the maximum at 10 μg/ml when com-
pared with vehicle control (Figure 1C). The protein of IL-8
also significantly increased at 2.5 μg/ml of H. TB, reaching
the maximum at 20 μg/ml when compared with vehicle
controls (Figure 1C).
Increased NF-κB subunits, and the role of NF-κB inhibitor
in the release of IP-10 and IL-8 in H. TB treated THP-1
cells
This study was designed to examine the modulatory role of
NKRF in regulation of IP-10 and IL-8. Therefore, a sub-
maximal concentration at 5 μg/ml was used to examine
the mechanisms for NKRF implicated in suppression of
IP-10 and IL-8 gene activation via an interference with
NF-κB p65. TransAM assay in THP-1 cells stimulated with
H. TB (5 μg/ml) for 2 hrs revealed an increase in NF-κB
subunits p65, p52, p50, C-Rel and RelB, respectively
(p < 0.05, n = 5) compare to vehicle control (Figure 2A).
THP-1 cells pretreated with a specific NF-κB inhibitor,
Helenalin (0.5 μM), suppressed H. TB induced IP-10 and
IL-8 release compared with those of control (Figure 2B),
indicating the release of IP-10 and IL-8 is mediated via
NF-κB. There was no significant cytotoxicity induced by
0.5 μMHelenalin (cell viability >96%, data not shown).
Figure 1 The activation of IP-10 and IL-8 in THP-1 cells treated with H. TB. (A) MTT cytotoxicity assay shows the cell viability of THP-1 cells
when treated with H. TB at variable concentrations (2.5, 5, 10, 20 μg/ml) for 6 hours. The cell viability decreased when THP-1 cells treated with H.
TB at the concentration of 20 μg/ml (n = 5) compared with control. (B) The expression of IP-10 (Left panel) and IL-8 (Right panel) mRNA in THP-1
(n = 5) cells was concentration-dependently increased when treated with H. TB for 2 hours, reaching the maximum at 10 μg/ml. (C) The release
of IP-10 and IL-8 proteins by THP-1 cells (n = 5) was concentration-dependently increased when treated with H. TB for 6 hours, reaching the
maximum at 10 μg/ml. Data are means ± SE. *p < 0.05, **p < 0.01 compare with the vehicle control.
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Quantification by quantitative RT-PCR demonstrated that
NKRF mRNA expression in THP-1 cells increased when
treated with H. TB (2.5, 5, 10, 20 μg/ml) for 2 hrs com-
pared with control (Figure 3A). Western Blot analysis
(Figure 3B left panel) and confocal microscopic analysis
(Figure 3B right panel) revealed a time-dependent increase
of NKRF protein in THP-1 cells. The Western blotting
(left panel) and confocal image analysis (right panel) for
H. TB induced NKRF expression revealed a maximal re-
sponse at concentration of 5 μg/ml, when THP-1 cellswere treated with H. TB (2.5, 5, 10, and 20 μg/ml) for
30 minutes.
NKRF binds the IP-10 and IL-8 promoter sites in H. TB
treated THP-1 cells
By binding to the NRE in the IL-8 promoter, NKRF
showed suppression of its basal transcription [28]. As
shown in our previous study, there is a specific NRE se-
quence in the promoter site of IP-10 (Table 1). To this
end, ChIP assay analysis with the antibody specific for
NKRF was used to study whether NKRF would bind to
Figure 2 (See legend on next page.)
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Figure 2 Increased NF-κB subunits, and the role of Helenalin in the release of IP-10 and IL-8. (A) TransAM assays to measure the NF-κB
subunits p65, p52, p50, C-Rel and RelB activities reveals an increase of p65, p52, C-Rel and RelB in THP-1 cells treated with 5 μg/ml H. TB at 2 hour
(n = 5). (B) The release of IP-10 (left panel) and of IL-8 (right panel) in THP-1 cells (n = 5) treated with H. TB for 6 hours was significantly inhibited
by a NF-κB specific inhibitor Helenalin (0.5 μM). Data are means ± SE. *p < 0.05, **p < 0.01 compared with corresponding vehicle control.
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The amount of IP-DNA was determined by RT-qPCR
using primer pairs amplifying a region around the NRE
site in the IP-10 or IL-8 promoter (Table 2). To de-
monstrate the site specificity of the assay, a primer pairFigure 3 Expression of NKRF in THP-1 cells treated with H. TB. (A) Tre
THP-1 cells (n = 5) significantly at the concentration of 5, 10 and 20 μg/ml.
panel) (n = 5) of THP-1 cells treated with H. TB at the concentration of 5 μg
Western blotting (left panel) and confocal image analysis (right panel) (n =
concentration of 5 μg/ml, when THP-1 cells were treated with H. TB (2.5, 5
**p < 0.01 compared with control.amplifying an irrelevant site around the 3′-UTR was also
used. IgG controls were used to demonstrate the specifi-
city of the antibody. In the vehicle control, a low but con-
sistently detected enrichment of IP-DNA over background
(the IgG control) was observed. In H. TB treated THP-1atment of H. TB for 2 hours increased the expression of NKRF mRNA in
(B) Westen blotting (left panel) and confocal image analysis (right
/ml revealed a time-dependent increase in NKRF expression. (C) The
5) for H. TB induced NKRF expression revealed a maximal response at
, 10, and 20 μg/ml) for 30 minutes. Data are means ± SE. *p < 0.05,
Table 1 Sequence comparison of the NRE sites in IP-10
and IL-8 promoters
Construct gene NRE sequence
IP-10 promoter (−503) AACTCCTGAGC (−493)
IL-8 promoter (−1415) AATTCCTCTGA (−1405)
NRE = negative response element; IP-10 = interferon gamma induced protein
10 kd; IL-8 = interleukin-8.
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promoters was significantly higher than those of control
(Figure 4A). In contrast, there was no significant change
in the IP-DNA when the primers for 3′-UTR were used
(data not shown). H. TB also induced increased occu-
pancy of NKRF to the promoters at IP-10 and IL-8 in
THP-1 cells (Figure 4B). The highest increase was found
in 1 hr (Figure 4C).
NKRF inhibits H. TB induced release of IP-10 and IL-8 in
THP-1 cells
We conducted in vitro experiments of NKRF knockdown
by transfection with siRNA targeting NKRF (NKRF-RNAi)
or non-targeting siRNA (scramble RNA) in THP-1 cells.
Transfection with NKRF-RNAi for 48 hrs significantlyTable 2 Transcript and sequence of each primer used in











For ChIP assays Primer
NKRF promoter, F: 5′-AGGTTCAAGCAGTTTTCC-3′
R: 5′-CTGTAATCTCAGCACTTTGG-3′
IP-10 promoter F: 5′-AGGCTGGTCTCAAACT-3′
R: 5′-CCTCCCACATCCAATTACT-3′










F = forward; R = reverse; IP-10 = Interferon gamma induced protein 10 kd;
IL-8 = interleukin-8; NKRF = NF-κB repressing factor; ChIP = chromatin
immunoprecipitation.decreased the level of NKRF mRNA compared with
scramble (55.2 ± 8.0% of scramble control, n = 5, p < 0.05
data not shown). MTT assays showed similar cellular via-
bility between NKRF-RNAi and scramble transfected cells
(96.6 ± 3.0% of control, n = 5, data not shown). Cells after
transfection were then treated with or without H. TB for 6
hrs, and the supernatants were collected for ELISA assay.
THP-1 cells transfected with NKRF-RNAi released a
greater levels of IP-10 and IL-8 proteins with or without
H. TB (5 μg/ml) treatment when compared with those
transfected with scramble (Figure 5A). These data indicate
that endogenous NKRF suppresses basal and H. TB in-
duced IP-10 and IL-8 production in THP-1 cells.
To delineate the mechanism underlying the up-regu-
lation of NKRF by H. TB, THP-1 cells were transfected
with plasmid DNA (p-CMV-vector and p-CMV-NKRF)
for 24 hrs, then exposed to H. TB. Lower protein levels of
IP-10 and IL-8 were produced by p-CMV-NKRF trans-
fected THP-1 cells than p-CMV-vector transfected cells
when exposed to 5 μg/ml of H. TB (Figure 5B). The ChIP
assays revealed overexpressions of NKRF by p-CMV-
NKRF transfection inhibited p65 binding to the promoter
sites of IP-10 and IL-8 at basal levels or after H. TB treat-
ment (5 μg/ml) when compared with p-CMV-vector
transfection (Figure 6A). Treatment with H. TB induced
recruitment of RNA polymerase II to the promoter sites
of IP-10 and IL-8 when compared with vehicle controls
(Figure 6B). Transfection with p-CMV-NKRF significantly
attenuated H. TB induced recruitment of RNA polyme-
rase II to either IP-10 or IL-8 promoter sites (Figure 6B).
These observations suggest that the intracellular NKRF
regulates the production of IP-10 and IL-8 via an inhi-
bition of p65 binding and RNA polymerase II recruitment
to both IP-10 and IL-8 promoter sites.
Discussion
The present study has demonstrated that direct exposure
to Mycobacterium TB induces increased mRNA synthesis
and release of IP-10 and IL-8 proteins, as well as a con-
comitant upregulation of NKRF mRNA and proteins in
mononuclear cells. The ChIP assay revealed that increased
NKRF nuclear translocation was associated with an in-
creased occupancy at the promoter sites of IP-10 and
IL-8. Over there, NKRF hindered NF-κB (p65) from bin-
ding to the promoter sites, and then prevented RNA poly-
merase II recruitment resulting in a decrease in mRNA
and protein synthesis of IP-10 and IL-8. Knockdown of
NKRF by siRNA augmented H. TB induced protein re-
lease of both IP-10 and IL-8. Furthermore, NKRF over-
expression suppressed H. TB induced release of IP-10 and
IL-8 proteins. Our results illustrate that NKRF can restrain
IP-10 and IL-8 expressions via hindering NF-κB (p65) and
RNA polymerase II from occupancy at the corresponding
promoter sites.
Figure 4 p65 and NKRF binding to IP-10 and IL-8 promoter sites by ChIP assays. (A) The ChIP assays showed a higher binding of p65 to IP-10
(left panel) and IL-8 (right panel) promoter sites in THP-1 cells treated with H. TB (5 μg/ml). (B) The ChIP assays showed a higher binding of NKRF to
IP-10 (left panel) and IL-8 (right panel) promoter sites in THP-1 cells treated with H. TB (5 μg/ml) (C) H. TB (5 μg/ml) induced NKRF binding to IP-10
(left panel) and IL-8 (right panel) promoter sites in THP-1 cells is time-dependent. Data are means ± SE. *p < 0.05, **p < 0.01 compared with control.
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published work [13], this study was designed to confirm
whether a direct contact of monocytes or alveolar macro-
phages with Mycobacteria might directly induce NKRF
without other immunological modifications as like in vivo.
Other immune cells, especially lymphocytes may have
primed circulating monocytes or alveolar macrophages
even retrieved from normal subjects in this country where
TB is highly prevalent and latent TB is difficult to be ex-
cluded. Thus, the mechanisms explored in primary cell
lines might provide more insight into the up-regulation ofNKRF and its interaction with NF-κB in regulation of
IP-10 and IL-8 release.
In pulmonary tuberculosis, the encounter between MTb
and the innate immune system induces a complicated and
sophisticated series of host responses. The next long-term
phase of the encounter is played by the activation of the
adaptive immune system. An important first step is to re-
cruit intravascular immune cells to the proximity of the
infective focus and prepare them for extravasation. In
pulmonary tuberculosis, the local generation of che-
mokines and immune regulation are responsible for the
Figure 5 Inhibition of NKRF increased the release of IP-10 and IL-8. (A) THP-1 cells transfected with siRNA targeting NKRF (NKRF-RNAi) for
48 hours significantly enhanced the release of IP-10 (left panel) and IL-8 (right panel) proteins with or without H. TB (5 μg/ml) stimulation, when
compared with corresponding scramble control (Scramble). (B) THP-1 cells transfected with NKRF plasmid (p-CMV-NKRF) for 24 hours significantly
decreased the protein levels of IP-10 (left panel) and IL-8 (right panel) in THP-1 cells with or without H. TB (5 μg/ml) stimulation, when compared
with corresponding vector control (p-CMV-vector). Data are means ± SE. *p < 0.05 compared with the corresponding group without H. TB treatment;
#p < 0.05 compared with the corresponding Scramble or vector control group.
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injured site [29]. The increased induction of C-X-C che-
mokines, IP-10 in MTb infection [9,13] attracts Th1-, Tc1-
activated lymphocytes and NK cells through CXCR3
[10-12]. IP-10 also can play a role in generation and func-
tion of effector T cells by promoting antigen-specific pro-
liferation and IFN-γ secretion [12,30,31]. IL-8 is involved
in monocyte, lymphocyte, and neutrophil recruitment
[32,33], and implicated in granuloma formation and main-
tenance in TB [21,34,35]. The present study demonstrated
that direct contacts with MTb induced mononuclear cells
to increase synthesis and release of IP-10 and IL-8, in-
dicating IP-10 and IL-8 are very important in the innate
immune response and bridges to the adaptive cellular
response.
NKRF plays a dual role in IL-1-induced IL-8 transcrip-
tion [27] and the binding to DNA specifically abolishes the
transcriptional activity of the bordering NF-κB-binding
sites by a noncompeting, distance and position-indepen-
dent mechanism [26]. In our previous study in human air-
way smooth muscle cells, NKRF inhibited neutrophil
elastase induced NF-κB transactivating activity or directly
suppressed the promoter site to modulate IL-8 synthesis
and protein release [36]. In alveolar macrophages and
peripheral blood mononuclear cells of pulmonary TB pa-
tients, knockdown of NKRF significantly increased IP-10and IL-8 release [13]. These results suggest NKRF may
serve as an endogenous repressor in IP-10 and IL-8
synthesis and release. However, NKRF was found up-
regulated to repress IP-10 and IL-8 release only in pul-
monary TB patients with high bacterial load [13]. In this
study, we have shown H. TB dose-dependently increased
NKRF expression in THP-1 cells, significantly at con-
centrations of H. TB more than 5 μg/ml, suggesting the in-
duction of NKRF synthesis might be directly related to
exposure to TB bacillus itself or its components.
MTb and its components also have been reported to
cause a constitutive degradation of IκB-α, leading to NF-κB
activation in monocytes from TB patients [37]. TransAM
assay in the present study showed H. TB exposure induced
activation of a variety of NF-κB subunits, predominantly
p65. A specific NF-κB inhibitor Helenalin suppressed
H. TB induced IP-10 and IL-8 release, suggesting both
IP-10 and IL-8 release were mainly mediated via NF-κB
activation, especially p65 subunit. Our previous study has
indicated that NF-κB activation induces NKRF synthesis
through NF-κB subunit p65 binding to the NKRF pro-
moter to transcriptionally activate NKRF mRNA synthesis
[36]. Thus, a direct contact with MTb induces NF-κB acti-
vation leading to up-regulation of IP-10 and IL-8 synthesis
and release in mononuclear cells. If bacterial load is high
enough, NF-κB activation may also induce a concomitant
Figure 6 NKRF overexpression can inhibit H. TB induced IP-10 and IL-8 release in THP-1 cells. THP-1 cells were transfected with NKRF plasmid
(p-CMV-NKRF) or control vector (p-CMV-vector) for 24 hours, and then incubated with H. TB (5 μg/ml) for 1 hr. ChIP assays were performed by using
p65 or RNA pol II antibodies. The IP-DNA was quantified by q-PCR with primer pairs specific to IP-10 and IL-8 promoter sites. Values were normalized
by input DNA. The ChIP assays showed a significantly decreased in p65 (A) and RNA pol II (B) binding to IP-10 (left panel) and IL-8 (right panel)
promoter sites in NKRF overexpress THP-1 cells treated with or without H. TB stimulation. Data are means ± SE. *p < 0.01, compared with the group
without H. TB treatment; #p < 0.05 compared with vector control group.
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of IP-10 and IL-8.
A further study to investigate whether H. TB induced
up-regulation of NKRF is mediated through NF-κB is
hindered by a concomitant NF-κB activation-increased
oxidative stress induced by H. TB stimulation. The high
levels of oxidative stress degrade NKRF as we have
reported in monocytes of COPD patients [38]. Thus,
modification of NF-κB activation by pharmacological in-
hibitors or by gene knock down or over-expression may
concomitantly influence the levels of intracellular oxi-
dants, leading to a difficulty in precisely representing the
causal-effect on NKRF synthesis in this experimental
model. In addition, we have also found distinct subunits
of NF-κB are activated by different concentrations of H.
TB. Whether distinct NF-κB subunits mediate diffe-
rential effects of H. TB on NKRF expression is currently
under study.
Our data display a great difference of increased activities
of p65 and NKRF to promoter of IP-10 and IL-8, i.e.NF-κB p65 expression was 2-fold for IP-10 and 15-fold for
IL-8. The possible explanation is that the IL-8 promoter is
predominantly activated by the induction of NF-κB
complex containing p65, though either AP-1 or C/EBP-β
may also play supporting roles [39,40]. However, IP-10
promoter is predominantly activated by an interferon-
stimulated response element, although there is also an
existent NF-κB responsive site that binds a p65 homodi-
mer. IP-10 gene activation is less dependent on NF-κB
p65, but only in maximal IP-10 expression, cooperation
between two sites is required [41]. Thus, the binding activ-
ities of NF-κB to promoter of IP-10 might be much lower
than those to IL-8 promoter.
Our ChIP assay used the same primer pairs (Table 2) to
amplify a region around the NRE site in the promoters of
IP-10 and IL-8. There was an increase in NKRF occupancy
at IP-10 and IL-8 promoter sites in the H. TB treated
group, suggesting an inhibition at the transcriptional
initiation. RNA interference and plasmid overexpres-
sion were performed to explore a link between NKRF
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thesis. In THP-1 cells, knockdown of NKRF augmented H.
TB induced IP-10 and IL-8 release, but overexpression of
NKRF attenuated the responses. Furthermore, in ChIP
assay we found that NKRF overexpression restrained p65
binding and RNA polymerase II recruitment to IP-10 and
IL-8 promoter sites. However, NKRF overexpression did
suppress the baseline IP-10 and IL-8 release, and H. TB
still induced IP-10 and IL-8 release from THP-1 cells.
Therefore, we suggest NF-κB might be also involved in the
basal release of IP-10 and IL-8. H. TB induced IP-10 and
IL-8 release is not completely inhibited by NKRF. H. TB
may act through NF-κB-independent pathways, such as
AP-1 or C/EBP-β or interferon-stimulated response ele-
ments to induce IL-8, or IP-10 release. Thus, NKRF in
THP-1 cells may serve as an endogenous repressor to pre-
vent robust increase in H. TB induced IP-10 and IL-8 re-
lease by interference with NF-κB transcriptional activity.
Conclusions
The results of this in vitro study are consistent with the
findings of our previous study that NKRF up-regulated ex-
pression in alveolar macrophages and peripheral blood
monocytes of active pulmonary TB patients represses IP-10
and IL-8 synthesis and release. This study further delineates
the underlying mechanisms that a direct contact with MTb
induces NKRF synthesis and nuclear translocation, binding
to NRE in the promoter sites of IP-10 and IL-8. Over there,
NKRF interferes with NF-κB (p65) binding and RNA poly-
merase II recruitment, leading to a repressive effect on
IP-10 and IL-8 synthesis.
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